STENT - VASCULAR RECONSTRUCTION UNKENTERPRISEENC

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,literature report with the FDA on 2020-03-04 for STENT - VASCULAR RECONSTRUCTION UNKENTERPRISEENC manufactured by Codman And Shurtleff, Inc.

Event Text Entries

[188230286] Product complaint #: (b)(4). Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made. Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer. Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.? Information regarding patient weight, height, medical history, race, and ethnicity was not reported. Cerenovus manufacturer's report numbers: 1226348-2020-00019, 1226348-2020-00020, 1226348-2020-00021. Are related to the same incident.
Patient Sequence No: 1, Text Type: N, H10


[188230287] This complaint is from a literature source. As reported in the literature publication entitled,? Outcome and prognostic factors of ruptured middle cerebral artery aneurysms treated via endovascular approach: a single-center 11-year experience? (pmid:31493611). 4 patients with ruptured middle cerebral artery (mca) aneurysms who underwent stent-assisted coiling experienced ischemic complication (side-branch occlusion). Objective: to investigate outcomes and prognostic factors of ruptured middle cerebral artery (mca) aneurysms, treated via endovascular approach, with improving treatment materials and techniques. Patients and methods: a total of 185 consecutive patients, admitted with acutely ruptured mca aneurysm sand treated by endovascular methods between 2006 and 2016, were retrospectively reviewed. Their baseline characteristics, procedure-related complications, and angio-graphic and clinical outcomes were collected.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1226348-2020-00018
MDR Report Key9787301
Report SourceFOREIGN,LITERATURE
Date Received2020-03-04
Date of Report2020-02-13
Date of Event2016-12-31
Date Mfgr Received2020-02-13
Date Added to Maude2020-03-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. GABRIEL ALFAGEME
Manufacturer Street31 TECHNOLOGY DRIVE
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone949789-868
Manufacturer G1CODMAN AND SHURTLEFF, INC
Manufacturer Street325 PARAMOUNT DR
Manufacturer CityRAYNHAM MA
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTENT - VASCULAR RECONSTRUCTION
Generic NameINTRACRANIAL NEUROVASCULAR STENT
Product CodeNJE
Date Received2020-03-04
Catalog NumberUNKENTERPRISEENC
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCODMAN AND SHURTLEFF, INC
Manufacturer Address325 PARAMOUNT DR RAYNHAM MA 02767 US 02767


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.